Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ploug

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Biochemistry|December 8, 1998
Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding siteM Ploug
Ugeskrift for Laeger|May 5, 1975
[Juvenile rheumatoid arthritis]K M Ploug-Sorensen
Current Medicinal Chemistry|October 16, 2008
The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibitionB Jacobsen, M Ploug
FEBS Letters|August 1, 1994
Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxinsM Ploug, V Ellis
The Journal of Biological Chemistry|December 23, 1999
Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesisH Gårdsvoll, K Danø, M Ploug
Biochemistry|August 2, 1994
Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptorM Ploug, V Ellis, K Danø
Stem Cells (Dayton, Ohio)|January 1, 1997
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPART Plesner, N Behrendt, M Ploug
Analytical Biochemistry|August 15, 1989
Determination of amino acid compositions and NH2-terminal sequences of peptides electroblotted onto PVDF membranes from tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis: application to peptide mapping of human complement component C3M Ploug, A L Jensen, V Barkholt
Electrophoresis|March 1, 1992
In situ alkylation of cysteine residues in a hydrophobic membrane protein immobilized on polyvinylidene difluoride membranes by electroblotting prior to microsequence and amino acid analysisM Ploug, B Stoffer, A L Jensen
European Journal of Biochemistry|September 1, 1992
Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activatorL B Møller, M Ploug, F Blasi
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Biochemistry|December 8, 1998
Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding siteM Ploug
Ugeskrift for Laeger|May 5, 1975
[Juvenile rheumatoid arthritis]K M Ploug-Sorensen
Current Medicinal Chemistry|October 16, 2008
The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibitionB Jacobsen, M Ploug
FEBS Letters|August 1, 1994
Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxinsM Ploug, V Ellis
The Journal of Biological Chemistry|December 23, 1999
Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesisH Gårdsvoll, K Danø, M Ploug
Biochemistry|August 2, 1994
Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptorM Ploug, V Ellis, K Danø
Stem Cells (Dayton, Ohio)|January 1, 1997
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPART Plesner, N Behrendt, M Ploug
Analytical Biochemistry|August 15, 1989
Determination of amino acid compositions and NH2-terminal sequences of peptides electroblotted onto PVDF membranes from tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis: application to peptide mapping of human complement component C3M Ploug, A L Jensen, V Barkholt
Electrophoresis|March 1, 1992
In situ alkylation of cysteine residues in a hydrophobic membrane protein immobilized on polyvinylidene difluoride membranes by electroblotting prior to microsequence and amino acid analysisM Ploug, B Stoffer, A L Jensen
European Journal of Biochemistry|September 1, 1992
Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activatorL B Møller, M Ploug, F Blasi
Pageof 4